Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin D. Witte is active.

Publication


Featured researches published by Martin D. Witte.


Nature Chemical Biology | 2010

Ultrasensitive in situ visualization of active glucocerebrosidase molecules

Martin D. Witte; Wouter W. Kallemeijn; Jan Aten; Kah-Yee Li; Anneke Strijland; Wilma E. Donker-Koopman; Adrianus M. C. H. van den Nieuwendijk; Boris Bleijlevens; Gertjan Kramer; Bogdan I. Florea; Berend Hooibrink; Carla E. M. Hollak; Roelof Ottenhoff; Rolf G. Boot; Gijsbert A. van der Marel; Herman S. Overkleeft; Johannes M. F. G. Aerts

Deficiency of glucocerebrosidase (GBA) underlies Gaucher disease, a common lysosomal storage disorder. Carriership for Gaucher disease has recently been identified as major risk for parkinsonism. Presently, no method exists to visualize active GBA molecules in situ. We here report the design, synthesis and application of two fluorescent activity-based probes allowing highly specific labeling of active GBA molecules in vitro and in cultured cells and mice in vivo. Detection of in vitro labeled recombinant GBA on slab gels after electrophoresis is in the low attomolar range. Using cell or tissue lysates, we obtained exclusive labeling of GBA molecules. We present evidence from fluorescence-activated cell sorting analysis, fluorescence microscopy and pulse-chase experiments of highly efficient labeling of GBA molecules in intact cells as well as tissues of mice. In addition, we illustrate the use of the fluorescent probes to study inhibitors and tentative chaperones in living cells.


Nature Protocols | 2013

Site-specific N-terminal labeling of proteins using sortase-mediated reactions

Christopher S. Theile; Martin D. Witte; Annet E M Blom; Lenka Kundrat; Hidde L. Ploegh; Carla P. Guimaraes

This protocol describes the use of sortase-mediated reactions to label the N terminus of any given protein of interest. The sortase recognition sequence, LPXTG (for Staphylococcus aureus sortase A) or LPXTA (for Streptococcus pyogenes sortase A), can be appended to a variety of probes such as fluorophores, biotin or even to other proteins. The protein to be labeled acts as a nucleophile by attacking the intermediate formed between the probe containing the LPXTG/A motif and the sortase enzyme. If sortase, the protein of interest and a suitably functionalized label are available, the reactions usually require less than 3 h.


Proceedings of the National Academy of Sciences of the United States of America | 2012

Preparation of unnatural N-to-N and C-to-C protein fusions

Martin D. Witte; Juan J. Cragnolini; Stephanie K. Dougan; Nicholas C. Yoder; Maximilian W. Popp; Hidde L. Ploegh

Standard genetic approaches allow the production of protein composites by fusion of polypeptides in head-to-tail fashion. Some applications would benefit from constructions that are genetically impossible, such as the site-specific linkage of proteins via their N or C termini, when a remaining free terminus is required for biological activity. We developed a method for the production of N-to-N and C-to-C dimers, with full retention of the biological activity of both fusion partners and without inflicting chemical damage on the proteins to be joined. We use sortase A to install on the N or C terminus of proteins of interest the requisite modifications to execute a strain-promoted copper-free cycloaddition and show that the ensuing ligation proceeds efficiently. Applied here to protein–protein fusions, the method reported can be extended to connecting proteins with any entity of interest.


Journal of Inherited Metabolic Disease | 2011

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

Johannes M. F. G. Aerts; Wouter W. Kallemeijn; Wouter Wegdam; Maria J. Ferraz; Mariëlle J. van Breemen; Nick Dekker; Gertjan Kramer; Ben J. H. M. Poorthuis; Johanna E. M. Groener; Josanne Cox-Brinkman; Saskia M. Rombach; Carla E. M. Hollak; Gabor E. Linthorst; Martin D. Witte; Henrik Gold; Gijs A. van der Marel; Herman S. Overkleeft; Rolf G. Boot

A biomarker is an analyte indicating the presence of a biological process linked to the clinical manifestations and outcome of a particular disease. In the case of lysosomal storage disorders (LSDs), primary and secondary accumulating metabolites or proteins specifically secreted by storage cells are good candidates for biomarkers. Clinical applications of biomarkers are found in improved diagnosis, monitoring disease progression, and assessing therapeutic correction. These are illustrated by reviewing the discovery and use of biomarkers for Gaucher disease and Fabry disease. In addition, recently developed chemical tools allowing specific visualization of enzymatically active lysosomal glucocerebrosidase are described. Such probes, coined inhibodies, offer entirely new possibilities for more sophisticated molecular diagnosis, enzyme replacement therapy monitoring, and fundamental research.


Angewandte Chemie | 2012

Novel Activity‐Based Probes for Broad‐Spectrum Profiling of Retaining β‐Exoglucosidases In Situ and In Vivo

Wouter W. Kallemeijn; Kah-Yee Li; Martin D. Witte; André Marques; Jan Aten; Saskia Scheij; Jianbing Jiang; Lianne I. Willems; Tineke Voorn-Brouwer; Cindy van Roomen; Roelof Ottenhoff; Rolf G. Boot; Hans van den Elst; Marthe T. C. Walvoort; Bogdan I. Florea; Jeroen D. C. Codée; Gijsbert A. van der Marel; Johannes M. F. G. Aerts; Herman S. Overkleeft

A high-end label: Cyclophellitol aziridine-type activity-based probes allow for ultra-sensitive visualization of mammalian β-glucosidases (GBA1, GBA2, GBA3, and LPH) as well as several non-mammalian β-glucosidases (see picture). These probes offer new ways to study β-exoglucosidases, and configurational isomers of the cyclophellitol aziridine core may give activity-based probes targeting other retaining glycosidase families.


Proceedings of the National Academy of Sciences of the United States of America | 2014

Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity

Koen Wagner; Mark J. Kwakkenbos; Yvonne B. Claassen; Kelly Maijoor; Martino Böhne; Koenraad F. van der Sluijs; Martin D. Witte; Diana van Zoelen; Lisette A. H. M. Cornelissen; Tim Beaumont; Arjen Q. Bakker; Hidde L. Ploegh; Hergen Spits

Significance Bispecific antibodies expand the function of conventional antibodies. However, therapeutic application of bispecifics is hampered by the reduced physiochemical stability of such molecules. We present a format for bispecific antibodies, fusing two full-sized antibodies via their C termini. This format does not require mutations in the antibody constant domains beyond installation of a five-residue tag, ensuring that the native antibody structure is fully retained in the bispecific product. We have validated the approach by linking two anti-influenza A antibodies, each active against a different subgroup of the virus. The bispecific antibody dimer retains the activity and the stability of the two original antibodies. Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodies. Many different formats of bispecific antibodies have meanwhile been developed. Most are genetic modifications of the antibody backbone to facilitate incorporation of two different variable domains into a single molecule. Here, we present a bispecific format where we have fused two full-sized IgG antibodies via their C termini using sortase transpeptidation and click chemistry to create a covalently linked IgG antibody heterodimer. By linking two potent anti-influenza A antibodies together, we have generated a full antibody dimer with bispecific activity that retains the activity and stability of the two fusion partners.


PLOS Pathogens | 2013

Bruton's Tyrosine Kinase (BTK) and Vav1 Contribute to Dectin1-Dependent Phagocytosis of Candida albicans in Macrophages

Karin Strijbis; Fikadu G. Tafesse; Gregory D. Fairn; Martin D. Witte; Stephanie K. Dougan; Nicki Watson; Eric Spooner; Alexandre Esteban; Valmik K. Vyas; Gerald R. Fink; Sergio Grinstein; Hidde L. Ploegh

Phagocytosis of the opportunistic fungal pathogen Candida albicans by cells of the innate immune system is vital to prevent infection. Dectin-1 is the major phagocytic receptor involved in anti-fungal immunity. We identify two new interacting proteins of Dectin-1 in macrophages, Brutons Tyrosine Kinase (BTK) and Vav1. BTK and Vav1 are recruited to phagocytic cups containing C. albicans yeasts or hyphae but are absent from mature phagosomes. BTK and Vav1 localize to cuff regions surrounding the hyphae, while Dectin-1 lines the full length of the phagosome. BTK and Vav1 colocalize with the lipid PI(3,4,5)P3 and F-actin at the phagocytic cup, but not with diacylglycerol (DAG) which marks more mature phagosomal membranes. Using a selective BTK inhibitor, we show that BTK contributes to DAG synthesis at the phagocytic cup and the subsequent recruitment of PKCε. BTK- or Vav1-deficient peritoneal macrophages display a defect in both zymosan and C. albicans phagocytosis. Bone marrow-derived macrophages that lack BTK or Vav1 show reduced uptake of C. albicans, comparable to Dectin1-deficient cells. BTK- or Vav1-deficient mice are more susceptible to systemic C. albicans infection than wild type mice. This work identifies an important role for BTK and Vav1 in immune responses against C. albicans.


Nature Protocols | 2013

Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry.

Martin D. Witte; Christopher S. Theile; Tongfei Wu; Carla P. Guimaraes; Annet E M Blom; Hidde L. Ploegh

Chimeric proteins, including bispecific antibodies, are biological tools with therapeutic applications. Genetic fusion and ligation methods allow the creation of N-to-C and C-to-N fused recombinant proteins, but not unnaturally linked N-to-N and C-to-C fusion proteins. This protocol describes a simple procedure for the production of such chimeric proteins, starting from correctly folded proteins and readily available peptides. By equipping the N terminus or C terminus of the proteins of interest with a set of click handles using sortase A, followed by a strain-promoted click reaction, unnatural N-to-N and C-to-C linked (hetero) fusion proteins are established. Examples of proteins that have been conjugated via this method include interleukin-2, interferon-α, ubiquitin, antibodies and several single-domain antibodies. If the peptides, sortase A and the proteins of interest are in hand, the unnaturally N-to-N and C-to-C fused proteins can be obtained in 3–4 d.


Angewandte Chemie | 2010

A Cleavable Linker Based on the Levulinoyl Ester for Activity-Based Protein Profiling

Paul P. Geurink; Bogdan I. Florea; Nan Li; Martin D. Witte; Joeri Verasdonck; Chi-Lin Kuo; Gijs A. van der Marel; Herman S. Overkleeft

The title linker is stable under various biological conditions and can be cleaved chemoselectively with hydrazine. Its use is demonstrated in the activity-based enrichment and identification of proteasome active subunits from cell extracts.


Journal of Experimental Medicine | 2014

Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells

Ana M. Avalos; Angelina M. Bilate; Martin D. Witte; Albert K. Tai; Jiang He; Maria P. Frushicheva; Peter Daniel Thill; Friederike Meyer-Wentrup; Christopher S. Theile; Arup K. Chakraborty; Xiaowei Zhuang; Hidde L. Ploegh

Monovalent engagement can trigger BCR signal transduction, and fine-tuning of BCR-ligand recognition can lead to B cell nonresponsiveness, activation, or inhibition.

Collaboration


Dive into the Martin D. Witte's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hidde L. Ploegh

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge